Brand Intelligence Graphcompany
Company Overview
About Recursion Pharmaceuticals
Recursion Pharmaceuticals (NASDAQ: RXRX) is a computational biology company industrializing drug discovery with AI, founded in 2013 in Salt Lake City, Utah. Built Recursion OS, a vertically integrated platform unifying biology, chemistry, and clinical development. Completed $688M all-stock Exscientia merger (November 2024). Market cap ~$1.62B.
Business Model & Competitive Advantage
2025 revenue $74.7M, net loss $929.8M. Cash: $755M (runway through 2027). Partnerships with Sanofi, Roche, Bayer, and Merck generated $500M+ in payments. In early 2026, Najat Khan became CEO as co-founder Chris Gibson moved to Chairman.
Competitive Landscape 2025–2026
Combined pipeline: 5 clinical programs, 15+ discovery programs. Lead asset REC-4881 (MEK1/2 inhibitor for FAP) showed 53% median polyp reduction in Phase 1b/2. Planning FDA engagement for registration pathway in H1 2026.
Recent Activity
View all →Key Differentiators
Strong Challenger
Recursion Pharmaceuticals is an established challenger with significant market presence and competitive offerings in Healthcare Tech.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
GE HealthCare
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin
Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company — publicly traded on the NASDAQ (NASDAQ: INCY) as an S&P 500 Health Care component — focused on oncology and inflammation,
Biogen
Biogen Inc. is a Cambridge, Massachusetts-based neuroscience biopharmaceutical company — publicly traded on NASDAQ (NASDAQ: BIIB) as an S&P 500 Health Care component — researching, developing, and com
Compare Recursion Pharmaceuticals with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Recursion Pharmaceuticals? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Recursion Pharmaceuticals Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Recursion Pharmaceuticals vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →